Central histaminergic system and cognition

Neuroscience and Biobehavioral Reviews

Volumn 24, Issue 1, 2000, Pages 107-113

  Passani, Maria Beatrice ^a   Bacciottini, Lucia ^a   Mannaioni, Pier Francesco ^a   Blandina, Patrizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FLUOROMETHYLHISTIDINE; ALPHA METHYLHISTAMINE; CLOBENPROPIT; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMETIT; NEUROTRANSMITTER; THIOPERAMIDE;

ADRENERGIC TRANSMISSION; ALZHEIMER DISEASE; AMNESIA; ATTENTION DEFICIT DISORDER; BEHAVIOR; BRAIN CORTEX; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; COGNITION; CONFERENCE PAPER; DOPAMINERGIC TRANSMISSION; FOREBRAIN; HISTAMINERGIC SYSTEM; HUMAN; HYPOTHALAMUS; LEARNING; MAMMILLARY BODY; NERVE CELL NETWORK; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PONS; PRIORITY JOURNAL; REGULATORY MECHANISM; TEGMENTUM; THALAMUS; TUBEROHYPOPHYSEAL TRACT;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM; COGNITION; HISTAMINE; HUMANS;

EID: 0033985806     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(99)00053-6     Document Type: Conference Paper

References (114)

1. Green J.P. Histamine and the nervous system. Fed Proc. 23:1964;1095-1102.
2. Haas H.L., Reiner P.B., Greene R.W. Histaminergic neurones: morpholory and function. Watanabe T., Wada H. Histaminergic neurones: morophology and function. 1991;196-208 CRC Press, Boca Roton, FL.
3. Onodera K., Yamatodani A., Watanabe T., Wada H. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Progr Neurobiol. 42:1994;685-702.
4. Watanabe T., Taguchi Y., Hayashi H., Tanaka J., Shiosaka S., Tohyama M., Kubota H., Terano Y., Wada H. Evidence for the presence of a histaminergic neuron system in the rat brain:an immunohistochemical analysis. Neurosci Lett. 39:1983;249-254.
5. Panula P., Yang H.Y., Costa E. Histamine-containing neurons in rat hypothalamus. Proc Natl Acad Sci USA. 81:1984;2572-2576.
6. 3) of histamine receptor. Nature. 302:1983;832-837.
7. Ash A.S.F., Schild H.O. Receptors mediating some actions of histamine. Br J Pharm Chemother. 27:1966;427-439.
8. 2-receptors. Nature. 236:1972;385-390.
9. Vorobjev V.S., Sharonova I.N., Walsh I.B., Haas H.L. Histamine potentiates N-methyl-D-aspartate responses in acutely isolated hippocampal neurons. Neuron. 11:1993;837-844.
10. Huston J.P., Wagner U., Hasenöhrl R.U. The tuberomammilary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav Brain Res. 83:1997;97-105.
11. The role of histamine on learning and memory. Tasaka K. New advances in histamine research. 1994;27-68 Springer, Berlin.
12. Ericson H., Watanable T., Köhler C. Morphological analysis of the tuberomammillary nucleus of the rat brain: delineation of subgroups with antibody against L-histidine decarboxylase as a marker. J Comp Neurol. 263:1987;1-24.
13. Steinbusch H.W.M., Mulder A. Immunohistochemical localization of histamine in neurons and mast cells in the rat brain. Biorklund A., Hökfelt T., Kuhar M.J. Handbook of chemical neuroanatomy, classical transmitters and transmitter receptors in central nervous system. 3:1984;126-140 Elsevier, Amsterdam.
14. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., Tohyama M., Wada H. Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 295:1984;13-25.
15. Bayliss D.A., Wang Y.M., Zahnow C.A., Joseph D.R., Milhorn D.E. Localization of histidine decarboxylase mRNA in rat brain. Mol Cell Neurosci. 1:1990;3-9.
16. Haas H.L., Reiner P.B. Membrane properties of histaminergic tuberomammilary neurones of the rat hypothalamus in vitro. J Physiol. 399:1988;633-646.
17. Inagaki N., Toda K., Taniuchi I., Panula P., Yamatodani A., Tohyama M., Watanabe T., Wada H. An analysis of histaminergic efferents of the tubermammillary nucleus to the medial preoptic area and inferior colliculus of the rat. Exp Brain Res. 80:1990;374-380.
18. Inagaki N., Yamatodani A., Ando-Yamamoto M., Tohyama M., Watanabe T., Wada H. Organization of histaminergic fibers in the rat brain. J Compl Neurol. 273:1988;283-300.
19. Panula P., Pirvola U., Auvinen S., Airaksinen M.N. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience. 28:1989;585-610.
20. Wada H., Inagaki N., Yamatodani A., Watanabe T. Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurol Sci. 14:1991;415-418.
21. Tohyama M., Tamiya R., Inagaki N., Tagaki H. Morphology of histaminergic neurons with histidine decarboxylase as a marker. Watanabe T., Wada H. Histaminergic neurons: morphology and function. 1991;107-126 CRC Press, Boca Roton, FL.
22. Inagaki N., Yamatodani A., Shinoda K., Shiotani Y., Tohyama M., Watanabe T., Wada H. The histaminergic innervation of the mesencephalic nucleus of trigeminal nerve in the rat brain: a light and electron microscopic study. Brain Res. 418:1987;388-391.
23. Ericson H.M. GABA-like immunoreactivity in the tuberomammillary nucleus in the rat brain: delineation of subgroups with antibody against L-histidine decarboxylase as a marker. J comp Neurol. 305:1991;462-469.
24. Takeda N., Inagaki S., Shiosaka S., Taguchi Y., Oertel W.H., Tohyama M., Watanabe T., Wada H. Immunocytochemical evidence for the coexistence of histidine decarboxylase and glutamate decarboxylase-like immunoreactivities in nerve cell of the posterior magnocellular nucleus of hypothalamus of rats. Proc Natl Acad Sci USA. 81:1984;7467-7650.
25. Senba E., Daddona P.E., Watanabe T., Wu J.Y., Nagy J.I. Coexistence of adenosine deaminase, histidine decarboxylase, and glutamate decarboxylase in hypothalamic neurons of the rat. J Neurosci. 5:1985;3393-3420.
26. Köhler C., Swanson L.W., Haglund L., Wu J.Y. The cytoarchitecture, histochemistry, and projections of the tuberomammillary nucleus in the rat. Neuroscience. 16:1985;85-110.
27. Köhler C., Erison H., Watanabe T., Polak J., Palay V., Chan-Palay V. Galanin immunoreactivity in hypothalamic histamine neurons: further evidence for multiple chemical messengers in the tuberomammillary nucleus. J Comp Neurol. 250:1986;58-64.
28. Airaksinen M.S. Multiple neurotransmitter in the tuberomammillary nucleus: comparison of rat, mouse and guinea pig. J Comp Neurol. 323:1992;103-116.
29. 125I]-iodobolpyramine. Neuroscience. 26:1988;553-600.
30. Haas H.L. Histamine hyperpolarizes hippocampal neurones in vitro. Neurosci Lett. 22:1981;75-78.
31. AHP to excite ferret vagal afferents. J Physiol. 503:1997;533-546.
32. 2 receptor and its gene transcripts in guinea-pig brain. Neuroscience. 80:1997;321-343.
33. Haas H.L., Konnerth A. Histamine and noradrenaline decrease calcium-activated potassium conductance in hippocampal pyramidal cells. Nature. 302:1983;432-434.
34. Yanovsky Y., Haas H.L. Histamine increases the bursting activity of pyramidal cells in the CA3 region of mouse hippocampus. Neurosci Lett. 240:1998;110-112.
35. Brown R.E., Fedorov N.B., Haas H.L., Reymann K.G. Histaminergic modulation of synaptic plasticity in area CA1 of rat hippocampal slices. Neuropharmacology. 34:1995;181-190.
36. 3 receptor a target for new drugs. 30:1998;1-12 Elsevier, Amsterdam.
37. 3-receptors. Neutoscience. 15:1985;553-562.
38. Hill S.J., Straw R.M. α2-Adrenoceptor-mediated inhibition of histamine release from rat cerebral cortical slices. Br J Pharmacol. 1998;1213-1219.
39. 3-receptors. Neuroscience. 23:1987;149-157.
40. 3 receptors. Nature. 327:1987;117-123.
41. Itoh Y., Oishi R., Adachi N., Seaki K. A highly sensitive assay for histamine using ion-pair HPLC coupled with postcolumn fluorescent derivatization: its application to biological specimens. J Neurochem. 58:1992;884-889.
42. Itoh Y., Oishi R., Nishibori M., Saeki K. Characterization of histamine release from the rat hypothalamus as measured by in vivo microdialysis. J Neurochem. 56:1991;769-774.
43. Prast H., Fisher H.P., Prast M., Philippu A. In vivo modulation of histamine release by autoreceptors and muscarinic acetycholine receptors in the rat anterior hypothalamus. Naunyn-Schmidedberg's Arch Pharmacol. 350:1994;599-604.
44. 3 receptor: characterization and autoradiographic localization in rat brain. Synapse. 8:1991;144-151.
45. 3) visualized in the brain of human and non human primates. Brain Res. 526:1990;322-327.
46. 3 receptors in rat brain areas. Neuroscience. 52:1993;169-189.
47. 3 receptor: a general presynaptic histaminergic regulatory system? Trends Pharmacol Sci. 10:1989;159-162.
48. 3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol. 337:1988;588-590.
49. 3 receptors. J Neural Transm. 93:1993;1-10.
50. 3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol. 340:1989;633-638.
51. Smits R.P.J.M., Mulder A.H. Inhibitory effects of histamine on the release of serotonin and noradrenaline from rat brain slices. Neurochem Int. 18:1991;215-220.
52. 3 receptors regulating acetylcholine release in rat enthorinal cortex. Br J Pharmacol. 114:1995;1518-1522.
53. 3 receptor subtypes. Br J Pharmacol. 107:1992;919-923.
54. 3 receptor activation in rats. Br J Pharmacol. 119:1996;1656-1664.
55. 3 receptor inhibition of k+-evoked release of acetylcholine from rat cortex in vivo. Ingflamm Res. 46:1997;S3-S4.
56. 3 antagonists modulate release of acetylcholine from the rat amygdala in vivo. Ann Meeting Eur Histamine Res Soc. 1999;33. Lyon (F): abs.
57. DeAlmeida M., Izquierdo I. Memory facilitation by histamine. Arch Int Pharmacodyn Ther. 283:1986;193-198.
58. 1-blockers. Jpn J Pharmacol. 57:1991;473-482.
59. 1-blockers on the step-through active avoidance response in rats. Psychoparmacology. 102:1990;312-318.
60. Miyazaki S., Imaizumi M., Onodera K. Ameliorating effects of histidine on scopolamine-induced learning deficits using an elevated plus-maze test in mice. Life Sci. 56:1995;1563-1570.
61. Prast H., Fisher H.P., Prast M., Phillippu A. Histaminergic neurons facilitate social memory in rats. Brain Res. 734:1996;316-318.
62. Watanable T., Yamatodani A., Maeyama K., Wada H. Pharmacology of α-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase. Trends Pharmacol Sci. 11:1990;363-366.
63. Kamei C., Okumura Y., Tasaka K. Influence of histamine depletion on learning and memory recollection in rats. Psychopharmacology. 111:1993;376-382.
64. Cacabelos R., Alvarez X.A. Histidine decarboxylase inhibition induced by α-fluoromethylhistidine provokes learning-related hypokinetic activity. Agents Actions. 33:1991;131-134.
65. Klapdor K., Hasenöhrl R.U., Huston J.P. Facilitation of learning in adult and aged rates following bilateral lesions of the tubermammilary nucleus region. Behav Brain Res. 61:1994;113-116.
66. Frisch C., Hasenöhrl R.U., Hass H.L., Weiler H.T., Steinbusch H.W.M., Huston J. Facilitation of learning after lesions of the tuberomammillary nucleus region in adult and aged rats. Exp Brain Res. 118:1998;447-456.
67. Miyazaki S., Imaizumi M., Onodera K. Effects of thioperamide on the cholinergic system and the step-through passive avoidance test in mice. Meth Find Exp Clin Pharmacol. 17:1995;653-658.
68. 3 receptors modulation of cortical cholinergic function: a parallel story. Meth Find Exp Clin Pharmacol. 20:1998;725-733.
69. 3 receptor agonist. J Pharmacol Exp Ther. 263:1992;304-310.
70. 2-muscarinic receptor antagonist in aged memory-impaired rats. J Neurosci. 15:1995;1455-1462.
71. 3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia. Behav Brain Res. 104:1999;147-155.
72. Smith C.P.S., Hunter A.J., Bennet G.W. Effects of (R)-α-methylhistamine and scopolamine on spatial learning in the rat assessed using a water maze. Psychopharmacology. 114:1994;651-656.
73. Goldman-Rakic P.S. Circuitry of primate prefrontal cortex and regulation of behavior by representational memory. Plum F. Handbook of Physiology. 5:1987;18-42 American Physiological Society, Bethesda, USA.
74. Page K.J., Everitt B.J., Robbins T.W., Marston H.M., Wilkinson L.S. Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA-and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss. Neuroscience. 43:1991;457-472.
75. O'Keefe J., Nadel L. The hippocampus as a cognitive map. 1978;Oxford University Press, Oxford.
76. Jäkälä P., Mazurkiewiscz M., Sirviö J., Riekkinen P., Riekkinen P. The behavioral effects of serotonin synthesis inhibition and quisqualic acid-induced lesions of the nucleus basalis magnocellularis in rats. Gen Pharmac. 24:1993;1141-1148.
77. Morris R.G.M., Garrud P., Rawlins J.N.P., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
78. 3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in mice. Life Sci. 57:1995;2137-2144.
79. 3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in mice. Life Sci. 61:1997;355-361.
80. 3 receptor agonists and antagonists. Trends Pharmacol Sci. 19:1998;177-183.
81. 3 receptor a target for new drugs. 30:1998;269-286 Elsevier, Amsterdam.
82. 3-receptors control histamine release in human brain. J Neurochem. 51:1988;105-108.
83. Hechtam L. Resilience and vulnerability in long term outcome of attention deficit hyperactive disorder. Can J Psychiatry. 36:1991;415-421.
84. Bellak L., Black R.B. Attention-deficit hyperactivity disorder in adults. Clin Ther. 14:1992;138-147.
85. Hechtman L. Genetic and neurobiological aspects of attention deficit hyperactive disorder: a review. J Psychiatry Neurosci. 19:1994;193-201.
86. Brazelli M., Columbo N., DellaSala S., Spinnler H. Spared and impaired cognitive abilities after bilateral frontal damage. Cortex. 30:1994;27-51.
87. Drewe E.A. Go/no-go learning after frontal lobe lesions in humans. Cortex. 11:1975;8-16.
88. Yamaguchi S., Knight R.T. Gating of somato-sensory input by human prefrontal cortex. Brain Res. 521:1990;281-288.
89. Bartus R.T., Levere T.E. Frontal decortication in rhesus monkeys: a test of the interference hypothesis. Brain Res. 119:1977;233-248.
90. Pearlson G.D., Robinson R.G. Suction lesions of the frontal cerebral cortex in the rat induced asymmetrical behavioral and catecholaminergic responses. Brain Res. 218:1981;233-242.
91. Starkstein S.E., Fedoroff P., Berthier M.L., Robinson R.G. Manic-depressive and pure manic states after brain lesions. Biol Psychiatry. 129:1991;149-158.
92. Wilkins A.J., Shallice T., McCarthy R. Frontal lesions and sustained attention. Neuropsychologia. 25:1987;359-365.
93. Chao L.L., Knight R.T. Human prefrontal lesions distractibility to irrelevant sensory inputs. Neuroreport. 6:1995;1605-1610.
94. Barkley R.A., Grodzinsky G., DuPaul G.J. Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report. J Abnorm Child Psychol. 20:1992;163-188.
95. Swanson J.M., Posner M., Potkin S., Bonforte S., Youpa D., Fiore C., Cantwell D., Crinella F. Activating tasks for the study of visual-spatial attention in ADHD children: a cognitive anatomic approach. J Child Neurol. 6:1991;S119-S127.
96. Hynd G.W., Semun-Clikeman M., Lorys A.R., Novey E.S., Eliopulos D. Brain morphology in development dyslexia and attention deficit disorder/hyperactivity. Arch Neurol. 47:1990;919-926.
97. Lou H.C., Henriksen L., Bruhn P. Focal cerebral dysfunction in developmental learning disabilities. Lancet. 335:1990;8-11.
98. Raskin L.A., Shaywitz B.A., Anderson G.M., Cohen J.D., Teicher M.H., Liakis J. Differential effects of selective dopamine, norepinephrine or catecholamine depletion on activity and learning in the developing rat. Pharmacol Biochem Behav. 19:1983;743-749.
99. Shaywitz B.A., Cohen J.D., Bowers M.B. CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. J Pediatr. 90:1977;67-71.
100. Shaywitz B.A., Teicher M.H., Cohen J.D., Anderson G.M., Young J.G., Levitt P. Dopaminergic but not noradrenergic modulation of hyperactivity and performance deficits in the developing rat pup. Psychopharmacology. 82:1984;73-77.
101. Shekim W.O., Dekirmenjian H., Chapel J.L. Urinary MHPG excretion in minimal brain dysfunction and its modification by D-amphetamine. Am J Psychiatry. 136:1979;667-671.
102. Lou H.C., Henriksen L., Bruhn P. Focal cerebral hypoperfusion in children with dysphasia and/or attention disorder. Arch Neurol. 41:1984;825-829.
103. Lou H.C., Henriksen L., Bruhn P., Borner H., Bieber Nielson J. Striatal dysfunction in attention deficit and hyperkinetic disorders. Arch Neurol. 46:1989;48-52.
104. Matochik J.A., Liebenauer L.L., King C.A., Szymanski H.V., Choen R.M., Zametkin A.J. Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment. Am J Psychiatry. 151:1994;658-664.
105. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science. 283:1999;397-401.
106. Peled O., Carraso R., Globman H., Yehuda S. Attention deficit disorder and hyperactivity-changes in hypothalamic function in hyperactive children: a new model. Med Hypotheses. 48:1997;267-275.
107. 3 receptor a target for new drugs. 30:1998;27-40 Elsevier, Amsterdam.
108. 3 receptor a target for new drugs. 30:1998;13-26 Elsevier, Amsterdam.
109. Valjakka A., Vartiainen J., Kosunen H., Hippeläine M., Pesola P., Olkkonen H., Airaksinen M.M., Tuomisto L. Histaminergic modulation of neocortical spindling and slow-wave activity in freely behaving rats. J Neural Transm. 103:1996;1265-1280.
110. Breese G.R., Taylor T.D. Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine. Br J Pharmacol. 44:1972;210-222.
111. Dumery V., Derer P., Blozovski D. Enhancement of passive avoidance learning through small doses of intra-amygdaloid physostigmine in the young rat. Its relation to the development of acetylcholinesterase. Dev Psychobiol. 21:1988;553-565.
112. Cornwell-jones C.A., Decker M.W., Chang J.W., Cole B., Goltz K.M., Tran T., McGaugh J.L. Neonatal 6-hydroxydopa, but not DSP-4, elevates brainstem monoamines and impairs inhibitory avoidance learning in developing rats. Brain Res. 493:1989;258-268.
113. Sagvolden T., Metzger M.A., Schiorbeck H.K., Rugland A.L., Spinnangr I., Sagvolden G. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav Neural Biol. 58:1992;103-112.
114. 3-receptor antagonist: in vitro and in vivo studies. J Pharmacol Exp Ther. 275:1995;598-604.